Antimicrobial Stewardship & Healthcare Epidemiology (Jan 2023)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations

  • Alexandra G. Mills,
  • Amy C. Dupper,
  • Kieran I. Chacko,
  • Bremy Alburquerque,
  • Devika Nadkarni,
  • Ana Berbel Caban,
  • Lindsey Fox,
  • Melissa R. Gitman,
  • Ajay Obla,
  • Harm van Bakel,
  • Deena R. Altman

DOI
https://doi.org/10.1017/ash.2023.163
Journal volume & issue
Vol. 3

Abstract

Read online

This case–control study of 25 cases with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with vancomycin minimum inhibitory concentration (MIC) ≥ 2 µg/mL and 391 controls (MIC < 2 µg/mL) characterized the clinical characteristics, treatments, and outcomes associated with elevated vancomycin MIC. Elevated vancomycin MIC was associated with baseline hemodialysis, prior MRSA colonization, and metastatic infection.